Strumento inattivo

Azioni Ablynx CBOE EUROPE EQUITIES

Azioni

Prezzo di chiusura CBOE EUROPE EQUITIES Altri mercati azionari
- ^EUR	-

02/07/09

Immunicum : and DCprime Combine Forces to Establish Leader in Cell-Based Cancer Immunotherapies	19/11/20
AstraZeneca : Novo Nordisk hires AstraZeneca executive to revive struggling biopharma unit	15/10/18
SANOFI : a finalisé l'acquisition d'Ablynx	19/06/18
Ablynx : SANOFI COMPLETES ITS ACQUITISION OF ABLYNX FOLLOWING THE EXPIRATION OF THE SQUEEZE-OUT PROCEDURE	19/06/18
Ablynx : PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")	28/05/18

Dirigenti	Titolo	Età	Da
Petrus Houwen CEO	Chief Executive Officer	-	01/04/19

Amministratori	Titolo	Età	Da
Kristine de Sutter BRD	Director/Board Member	-	01/04/19
Pieter Oldenziel BRD	Director/Board Member	-	01/01/19

Settore

	Variaz. 1 gen.	Capi.
MODERNA, INC.	+23,13%	46,93 Mrd
LONZA GROUP AG	+37,01%	39,08 Mrd
IQVIA HOLDINGS INC.	-8,73%	38,48 Mrd
ALNYLAM PHARMACEUTICALS, INC.	+28,09%	31,01 Mrd
CELLTRION, INC.	-12,26%	26,14 Mrd
ICON PUBLIC LIMITED COMPANY	+10,57%	25,88 Mrd
UNITED THERAPEUTICS CORPORATION	+45,05%	14,15 Mrd
MEDPACE HOLDINGS, INC.	+32,23%	12,53 Mrd
BIO-TECHNE CORPORATION	-6,56%	11,36 Mrd